Loading…
N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography
Background We investigated the ability of cardiac biomarkers and total pulmonary artery (PA) clot score to predict right ventricular dysfunction (RVD) on admission and at seven-month follow-up in subjects with acute pulmonary embolism (APE). Methods Sixty-three normotensive patients with APE were di...
Saved in:
Published in: | Heart, lung & circulation lung & circulation, 2016-06, Vol.25 (6), p.592-599 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53 |
---|---|
cites | cdi_FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53 |
container_end_page | 599 |
container_issue | 6 |
container_start_page | 592 |
container_title | Heart, lung & circulation |
container_volume | 25 |
creator | Granér, Marit, MD, PhD Harjola, Veli-Pekka, MD, PhD Selander, Tuomas, MSc Laiho, Mia K., MD, PhD Piilonen, Anneli, MD Raade, Merja, MD Mustonen, Pirjo, MD, PhD |
description | Background We investigated the ability of cardiac biomarkers and total pulmonary artery (PA) clot score to predict right ventricular dysfunction (RVD) on admission and at seven-month follow-up in subjects with acute pulmonary embolism (APE). Methods Sixty-three normotensive patients with APE were divided into two groups: patients with (n= 32, age 58 ± 19 years) and without (n=31, age 55 ± 16 years) echocardiographic RVD. Transthoracic echocardiography (TTE), N-terminal pro-brain natriuretic peptide (NT-proBNP), and high-sensitivity troponin T (hsTnT) were assessed upon arrival and repeated at seven months. Total PA clot score was determined on admission. Results The age- and sex dependent NT-proBNP on admission, on day 5, and at seven months exhibited the best sensitivity (admission 94%, day 5 100%, seven months 100%) and negative predictive value (NPV) (89%, 100%, 100%) for detecting RVD. Six patients (10%) had persistent RVD at seven months. Total PA clot score showed only low to moderate sensitivity (77%) and PPV (7%) for detection of RVD at seven months. Conclusions Normal age- and sex dependent NT-proBNP on admission or measured five days later seems to be useful in exclusion of RVD at follow up. Total PA clot score shows only to be of modest benefit for predicting persistent RVD. |
doi_str_mv | 10.1016/j.hlc.2015.12.004 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1786523738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1443950615015243</els_id><sourcerecordid>1786523738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEoqXwAGyQlyxI8F_-hIRUDaVFqsqIFraWx77ueEjs1HYq5YV4znqYwoIFK9_FOZ917rlF8ZrgimDSvN9V20FVFJO6IrTCmD8pjgnnvKRdT5_-nlnZ17g5Kl7EuMOYtJz1z4sj2nS45w07Ln5dlQnCaJ0c0Dr4chOkdehKpmDnAMkqtIYpWQ3v0IW93ZYRXLTJ3tu0oJvgJ--yXDqN1vMweifDgk5DJi5oNfiErpUPgGTMbNBWJR8i8gZ9y6iEfoDL36h5kAF9WqKZnUrWO5SJZ2rrlQza-tsgp-3ysnhm5BDh1eN7Unz_fHazuigvv55_WZ1elorXJJW0l7rBDRgpOatzwp4b1ZGmIYbVHHPdM9UaRU0rMWvxxphNU3O5MZoZinXNToq3B-4U_N0MMYnRRgXDIB34OQrSdk1NWcu6LCUHqQo-xgBGTMGOeQGCYLGvR-xErkfs6xGEilxP9rx5xM-bEfRfx58-suDDQQA55L2FIKKy4FReXgCVhPb2v_iP_7jVYJ1VcvgJC8Sdn0PuOacQMRvE9f4-9udB6gyhnLEH2tW4oQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786523738</pqid></control><display><type>article</type><title>N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Granér, Marit, MD, PhD ; Harjola, Veli-Pekka, MD, PhD ; Selander, Tuomas, MSc ; Laiho, Mia K., MD, PhD ; Piilonen, Anneli, MD ; Raade, Merja, MD ; Mustonen, Pirjo, MD, PhD</creator><creatorcontrib>Granér, Marit, MD, PhD ; Harjola, Veli-Pekka, MD, PhD ; Selander, Tuomas, MSc ; Laiho, Mia K., MD, PhD ; Piilonen, Anneli, MD ; Raade, Merja, MD ; Mustonen, Pirjo, MD, PhD</creatorcontrib><description>Background We investigated the ability of cardiac biomarkers and total pulmonary artery (PA) clot score to predict right ventricular dysfunction (RVD) on admission and at seven-month follow-up in subjects with acute pulmonary embolism (APE). Methods Sixty-three normotensive patients with APE were divided into two groups: patients with (n= 32, age 58 ± 19 years) and without (n=31, age 55 ± 16 years) echocardiographic RVD. Transthoracic echocardiography (TTE), N-terminal pro-brain natriuretic peptide (NT-proBNP), and high-sensitivity troponin T (hsTnT) were assessed upon arrival and repeated at seven months. Total PA clot score was determined on admission. Results The age- and sex dependent NT-proBNP on admission, on day 5, and at seven months exhibited the best sensitivity (admission 94%, day 5 100%, seven months 100%) and negative predictive value (NPV) (89%, 100%, 100%) for detecting RVD. Six patients (10%) had persistent RVD at seven months. Total PA clot score showed only low to moderate sensitivity (77%) and PPV (7%) for detection of RVD at seven months. Conclusions Normal age- and sex dependent NT-proBNP on admission or measured five days later seems to be useful in exclusion of RVD at follow up. Total PA clot score shows only to be of modest benefit for predicting persistent RVD.</description><identifier>ISSN: 1443-9506</identifier><identifier>EISSN: 1444-2892</identifier><identifier>DOI: 10.1016/j.hlc.2015.12.004</identifier><identifier>PMID: 26809463</identifier><language>eng</language><publisher>Australia: Elsevier B.V</publisher><subject>Adult ; Aged ; Biomarkers - blood ; Cardiac biomarkers ; Cardiovascular ; Echocardiography ; Female ; Humans ; Male ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Peptide Fragments - blood ; Pulmonary Artery - diagnostic imaging ; Pulmonary artery clot score ; Pulmonary embolism ; Pulmonary Embolism - blood ; Pulmonary Embolism - diagnostic imaging ; Right ventricular dysfunction ; Thrombosis - blood ; Thrombosis - diagnostic imaging ; Troponin - blood ; Ventricular Dysfunction, Right - blood ; Ventricular Dysfunction, Right - diagnostic imaging</subject><ispartof>Heart, lung & circulation, 2016-06, Vol.25 (6), p.592-599</ispartof><rights>Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)</rights><rights>2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)</rights><rights>Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53</citedby><cites>FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26809463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Granér, Marit, MD, PhD</creatorcontrib><creatorcontrib>Harjola, Veli-Pekka, MD, PhD</creatorcontrib><creatorcontrib>Selander, Tuomas, MSc</creatorcontrib><creatorcontrib>Laiho, Mia K., MD, PhD</creatorcontrib><creatorcontrib>Piilonen, Anneli, MD</creatorcontrib><creatorcontrib>Raade, Merja, MD</creatorcontrib><creatorcontrib>Mustonen, Pirjo, MD, PhD</creatorcontrib><title>N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography</title><title>Heart, lung & circulation</title><addtitle>Heart Lung Circ</addtitle><description>Background We investigated the ability of cardiac biomarkers and total pulmonary artery (PA) clot score to predict right ventricular dysfunction (RVD) on admission and at seven-month follow-up in subjects with acute pulmonary embolism (APE). Methods Sixty-three normotensive patients with APE were divided into two groups: patients with (n= 32, age 58 ± 19 years) and without (n=31, age 55 ± 16 years) echocardiographic RVD. Transthoracic echocardiography (TTE), N-terminal pro-brain natriuretic peptide (NT-proBNP), and high-sensitivity troponin T (hsTnT) were assessed upon arrival and repeated at seven months. Total PA clot score was determined on admission. Results The age- and sex dependent NT-proBNP on admission, on day 5, and at seven months exhibited the best sensitivity (admission 94%, day 5 100%, seven months 100%) and negative predictive value (NPV) (89%, 100%, 100%) for detecting RVD. Six patients (10%) had persistent RVD at seven months. Total PA clot score showed only low to moderate sensitivity (77%) and PPV (7%) for detection of RVD at seven months. Conclusions Normal age- and sex dependent NT-proBNP on admission or measured five days later seems to be useful in exclusion of RVD at follow up. Total PA clot score shows only to be of modest benefit for predicting persistent RVD.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Cardiac biomarkers</subject><subject>Cardiovascular</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Peptide Fragments - blood</subject><subject>Pulmonary Artery - diagnostic imaging</subject><subject>Pulmonary artery clot score</subject><subject>Pulmonary embolism</subject><subject>Pulmonary Embolism - blood</subject><subject>Pulmonary Embolism - diagnostic imaging</subject><subject>Right ventricular dysfunction</subject><subject>Thrombosis - blood</subject><subject>Thrombosis - diagnostic imaging</subject><subject>Troponin - blood</subject><subject>Ventricular Dysfunction, Right - blood</subject><subject>Ventricular Dysfunction, Right - diagnostic imaging</subject><issn>1443-9506</issn><issn>1444-2892</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9ks1u1DAUhSMEoqXwAGyQlyxI8F_-hIRUDaVFqsqIFraWx77ueEjs1HYq5YV4znqYwoIFK9_FOZ917rlF8ZrgimDSvN9V20FVFJO6IrTCmD8pjgnnvKRdT5_-nlnZ17g5Kl7EuMOYtJz1z4sj2nS45w07Ln5dlQnCaJ0c0Dr4chOkdehKpmDnAMkqtIYpWQ3v0IW93ZYRXLTJ3tu0oJvgJ--yXDqN1vMweifDgk5DJi5oNfiErpUPgGTMbNBWJR8i8gZ9y6iEfoDL36h5kAF9WqKZnUrWO5SJZ2rrlQza-tsgp-3ysnhm5BDh1eN7Unz_fHazuigvv55_WZ1elorXJJW0l7rBDRgpOatzwp4b1ZGmIYbVHHPdM9UaRU0rMWvxxphNU3O5MZoZinXNToq3B-4U_N0MMYnRRgXDIB34OQrSdk1NWcu6LCUHqQo-xgBGTMGOeQGCYLGvR-xErkfs6xGEilxP9rx5xM-bEfRfx58-suDDQQA55L2FIKKy4FReXgCVhPb2v_iP_7jVYJ1VcvgJC8Sdn0PuOacQMRvE9f4-9udB6gyhnLEH2tW4oQ</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Granér, Marit, MD, PhD</creator><creator>Harjola, Veli-Pekka, MD, PhD</creator><creator>Selander, Tuomas, MSc</creator><creator>Laiho, Mia K., MD, PhD</creator><creator>Piilonen, Anneli, MD</creator><creator>Raade, Merja, MD</creator><creator>Mustonen, Pirjo, MD, PhD</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160601</creationdate><title>N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography</title><author>Granér, Marit, MD, PhD ; Harjola, Veli-Pekka, MD, PhD ; Selander, Tuomas, MSc ; Laiho, Mia K., MD, PhD ; Piilonen, Anneli, MD ; Raade, Merja, MD ; Mustonen, Pirjo, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Cardiac biomarkers</topic><topic>Cardiovascular</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Peptide Fragments - blood</topic><topic>Pulmonary Artery - diagnostic imaging</topic><topic>Pulmonary artery clot score</topic><topic>Pulmonary embolism</topic><topic>Pulmonary Embolism - blood</topic><topic>Pulmonary Embolism - diagnostic imaging</topic><topic>Right ventricular dysfunction</topic><topic>Thrombosis - blood</topic><topic>Thrombosis - diagnostic imaging</topic><topic>Troponin - blood</topic><topic>Ventricular Dysfunction, Right - blood</topic><topic>Ventricular Dysfunction, Right - diagnostic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Granér, Marit, MD, PhD</creatorcontrib><creatorcontrib>Harjola, Veli-Pekka, MD, PhD</creatorcontrib><creatorcontrib>Selander, Tuomas, MSc</creatorcontrib><creatorcontrib>Laiho, Mia K., MD, PhD</creatorcontrib><creatorcontrib>Piilonen, Anneli, MD</creatorcontrib><creatorcontrib>Raade, Merja, MD</creatorcontrib><creatorcontrib>Mustonen, Pirjo, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Heart, lung & circulation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Granér, Marit, MD, PhD</au><au>Harjola, Veli-Pekka, MD, PhD</au><au>Selander, Tuomas, MSc</au><au>Laiho, Mia K., MD, PhD</au><au>Piilonen, Anneli, MD</au><au>Raade, Merja, MD</au><au>Mustonen, Pirjo, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography</atitle><jtitle>Heart, lung & circulation</jtitle><addtitle>Heart Lung Circ</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>25</volume><issue>6</issue><spage>592</spage><epage>599</epage><pages>592-599</pages><issn>1443-9506</issn><eissn>1444-2892</eissn><abstract>Background We investigated the ability of cardiac biomarkers and total pulmonary artery (PA) clot score to predict right ventricular dysfunction (RVD) on admission and at seven-month follow-up in subjects with acute pulmonary embolism (APE). Methods Sixty-three normotensive patients with APE were divided into two groups: patients with (n= 32, age 58 ± 19 years) and without (n=31, age 55 ± 16 years) echocardiographic RVD. Transthoracic echocardiography (TTE), N-terminal pro-brain natriuretic peptide (NT-proBNP), and high-sensitivity troponin T (hsTnT) were assessed upon arrival and repeated at seven months. Total PA clot score was determined on admission. Results The age- and sex dependent NT-proBNP on admission, on day 5, and at seven months exhibited the best sensitivity (admission 94%, day 5 100%, seven months 100%) and negative predictive value (NPV) (89%, 100%, 100%) for detecting RVD. Six patients (10%) had persistent RVD at seven months. Total PA clot score showed only low to moderate sensitivity (77%) and PPV (7%) for detection of RVD at seven months. Conclusions Normal age- and sex dependent NT-proBNP on admission or measured five days later seems to be useful in exclusion of RVD at follow up. Total PA clot score shows only to be of modest benefit for predicting persistent RVD.</abstract><cop>Australia</cop><pub>Elsevier B.V</pub><pmid>26809463</pmid><doi>10.1016/j.hlc.2015.12.004</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1443-9506 |
ispartof | Heart, lung & circulation, 2016-06, Vol.25 (6), p.592-599 |
issn | 1443-9506 1444-2892 |
language | eng |
recordid | cdi_proquest_miscellaneous_1786523738 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adult Aged Biomarkers - blood Cardiac biomarkers Cardiovascular Echocardiography Female Humans Male Middle Aged Natriuretic Peptide, Brain - blood Peptide Fragments - blood Pulmonary Artery - diagnostic imaging Pulmonary artery clot score Pulmonary embolism Pulmonary Embolism - blood Pulmonary Embolism - diagnostic imaging Right ventricular dysfunction Thrombosis - blood Thrombosis - diagnostic imaging Troponin - blood Ventricular Dysfunction, Right - blood Ventricular Dysfunction, Right - diagnostic imaging |
title | N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T19%3A57%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-terminal%20Pro-brain%20Natriuretic%20Peptide,%20High-sensitivity%20Troponin%20and%20Pulmonary%20Artery%20Clot%20Score%20as%20Predictors%20of%20Right%20Ventricular%20Dysfunction%20in%20Echocardiography&rft.jtitle=Heart,%20lung%20&%20circulation&rft.au=Gran%C3%A9r,%20Marit,%20MD,%20PhD&rft.date=2016-06-01&rft.volume=25&rft.issue=6&rft.spage=592&rft.epage=599&rft.pages=592-599&rft.issn=1443-9506&rft.eissn=1444-2892&rft_id=info:doi/10.1016/j.hlc.2015.12.004&rft_dat=%3Cproquest_cross%3E1786523738%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-29ad606efaa43594694fc81661f35404d93c7fc2f7a0370bffb654abfd3f20d53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1786523738&rft_id=info:pmid/26809463&rfr_iscdi=true |